326 related articles for article (PubMed ID: 33758518)
1. Prevalence of Multidrug-Resistant Tuberculosis in Dalian, China: A Retrospective Study.
Du L; Zhang Y; Lv X; Duan Y; Shi X; Ji H; Wu R; Xu J; Chen X; Gao Y; Lu X; Zhou L
Infect Drug Resist; 2021; 14():1037-1047. PubMed ID: 33758518
[TBL] [Abstract][Full Text] [Related]
2. Drug Resistance Patterns and Trends in Patients with Suspected Drug-Resistant Tuberculosis in Dalian, China: A Retrospective Study.
Pan Y; Yu Y; Lu J; Yi Y; Dou X; Zhou L
Infect Drug Resist; 2022; 15():4137-4147. PubMed ID: 35937782
[TBL] [Abstract][Full Text] [Related]
3. Quinolones and multidrug-resistant tuberculosis.
Maranetra KN
Chemotherapy; 1999; 45 Suppl 2():12-8. PubMed ID: 10449893
[TBL] [Abstract][Full Text] [Related]
4. Drug Resistance Characteristics of
Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
[No Abstract] [Full Text] [Related]
5. Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014.
Chuang PH; Wu MH; Fan SY; Lin KY; Jou R
PLoS One; 2016; 11(11):e0165222. PubMed ID: 27846235
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
Che Y; Bo D; Lin X; Chen T; He T; Lin Y
BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989
[TBL] [Abstract][Full Text] [Related]
7. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Sheed Khan A; Nadeem T; Zeb MT; Masood N; Afzal MT
Microb Drug Resist; 2018 Nov; 24(9):1417-1421. PubMed ID: 29584579
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
[TBL] [Abstract][Full Text] [Related]
11. Survey of tuberculosis drug resistance among Tibetan refugees in India.
Salvo F; Dorjee K; Dierberg K; Cronin W; Sadutshang TD; Migliori GB; Rodrigues C; Trentini F; Di Serio C; Chaisson R; Cirillo DM
Int J Tuberc Lung Dis; 2014 Jun; 18(6):655-62. PubMed ID: 24903934
[TBL] [Abstract][Full Text] [Related]
12. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
13. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
14. High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India.
Selvakumar N; Kumar V; Balaji S; Prabuseenivasan S; Radhakrishnan R; Sekar G; Chandrasekaran V; Kannan T; Thomas A; Arunagiri S; Dewan P; Swaminathan S
PLoS One; 2015; 10(3):e0117421. PubMed ID: 25738956
[TBL] [Abstract][Full Text] [Related]
15. Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India.
Mamatha HG; Shanthi V
J Glob Antimicrob Resist; 2018 Mar; 12():5-10. PubMed ID: 28887289
[TBL] [Abstract][Full Text] [Related]
16. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
[TBL] [Abstract][Full Text] [Related]
17. Treatment of multidrug-resistant tuberculosis in Thailand.
Maranetra KN
Chemotherapy; 1996; 42 Suppl 3():10-5; discussion 30-3. PubMed ID: 8980862
[TBL] [Abstract][Full Text] [Related]
18. Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study.
Huang H; Zhang Y; Li S; Wang J; Chen J; Pan Z; Gan H
Microb Drug Resist; 2018 Jun; 24(5):675-679. PubMed ID: 29053085
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
Porwal C; Kaushik A; Makkar N; Banavaliker JN; Hanif M; Singla R; Bhatnagar AK; Behera D; Pande JN; Singh UB
PLoS One; 2013; 8(2):e55299. PubMed ID: 23390524
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.
Yadav RN; Singh BK; Sharma SK; Sharma R; Soneja M; Sreenivas V; Myneedu VP; Hanif M; Kumar A; Sachdeva KS; Paramasivan CN; Vollepore B; Thakur R; Raizada N; Arora SK; Sinha S
PLoS One; 2013; 8(9):e72036. PubMed ID: 24039735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
